Direct access to more than 75 hospitals and site management organisations, each with a registered ethics committee, and a pool of 125+ trained investigators. This footprint enables rapid feasibility, faster activation and access to diverse patient populations.
Experienced investigators covering all major therapeutic areas, with particular depth in oncology. Our teams have designed and executed complex study protocols across a broad spectrum of indications and patient profiles.
An exclusive tie-up for molecular diagnostics supports advanced, biomarker-driven study designs. This capability enables precise patient stratification, companion-diagnostic workflows and translational endpoints.
An NABL-accredited in-house diagnostic laboratory, backed by a dedicated logistics network spanning India, ensures sample integrity from collection to analysis and shortens turnaround for time-critical endpoints.
Therapeutic Focus
Depth led by oncology, extending across a broad range of therapeutic areas — supported by investigators experienced in designing and running complex protocols.
Solid tumours and haemato-oncology, including complex confirmatory and exploratory designs.
Topical and systemic programs, from psoriasis to consumer-health formulations.
Metabolic and glycaemic-control studies with rigorous endpoint capture.
Anaemia and blood-disorder trials, including iron-deficiency programs.
Anti-infective and wound-healing studies with careful safety oversight.
Immune-mediated and inflammatory indications across multiple phases.
Cardiovascular and metabolic outcome studies with robust monitoring.
Central-nervous-system programs demanding precise endpoint methodology.
Airway and pulmonary studies across chronic and acute presentations.
Explore our service lines or speak with our team about how our network and labs can accelerate your study.